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In the subthalamic nucleus (STN) of Parkinson’s disease (PD) patients, a pronounced synchronization of oscillatory activity at beta
frequencies (15–30 Hz) accompanies movement difficulties. Abnormal beta oscillations and motor symptoms are concomitantly and
acutelysuppressedbydopaminergictherapies,suggestingthattheseinappropriaterhythmsmightalsoemergeacutelyfromdisrupted
dopamine transmission. The neural basis of these abnormal beta oscillations is unclear, and how they might compromise information
processing,orhowtheyarise,isunknown.Usinga6-hydroxydopamine-lesionedrodentmodelofPD,wedemonstratethatbetaoscilla-
tions are inappropriately exaggerated, compared with controls, in a brain-state-dependent manner after chronic dopamine loss. Exag-
geratedbetaoscillationsareexpressedatthelevelsofsingleneuronsandsmallneuronalensembles,andarefocallypresentandspatially
distributedwithinSTN.Theyarealsoexpressedinsynchronouspopulationactivities,asevincedbyoscillatorylocalfieldpotentials,in
STN and cortex. Excessively synchronized beta oscillations reduce the information coding capacity of STN neuronal ensembles, which
maycontributetoparkinsonianmotorimpairment.Acutedisruptionofdopaminetransmissionincontrolanimalswithantagonistsof
D1/D2receptorsdidnotexaggerateSTNorcorticalbetaoscillations.Moreover,betaoscillationswerenotexaggerateduntilseveraldays
after6-hydroxydopamineinjections.Thus,contrarytopredictions,abnormallyamplifiedbetaoscillationsincortico-STNcircuitsdonot
resultsimplyfromanacuteabsenceofdopaminereceptorstimulation,butareinsteaddelayedsequelaeofchronicdopaminedepletion.
Targeting the plastic processes underlying the delayed emergence of pathological beta oscillations after continuing dopaminergic dys-
functionmayofferconsiderabletherapeuticpromise.
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Introduction
The frequency characteristics of brain activity vary predictably
with behavior (Steriade, 2000; Buzsaki and Draguhn, 2004). The
neurotransmitter dopamine is particularly important in coordi-
natingneuronalactivityacrossdifferentfrequenciesduringexec-
utive processes. Acute disruption of dopamine transmission,
through blockade of receptors or synthesis, rapidly restructures
the spectral pattern of activity within and between the basal gan-
glia and cerebral cortex (Degos et al., 2005; Costa et al., 2006;
Burkhardtetal.,2007).Behaviorchangesaccordingly,withacute
disruptions producing severe motor deficits such as catalepsy
(Ayd, 1961).
Chronic disruption of dopamine transmission also greatly af-
fects frequency-domain interactions, as exemplified in Parkin-
son’s disease (PD), in which midbrain dopamine neurons pro-
gressively die. Excessive synchronization of neuronal activity,
and particularly oscillations, is a critical functional change ac-
companying Parkinsonism (Bergman et al., 1998; Boraud et al.,
2005; Gatev et al., 2006; Hammond et al., 2007). In PD patients,
synchronization within and between the rhythmic activities of
single neurons and/or neuronal populations in the basal ganglia,
particularlythesubthalamicnucleus(STN),andcortexpreferen-
tially occurs at beta (15–30 Hz) frequencies (Brown et al., 2001;
Levyetal.,2002;Amirnovinetal.,2004;Kuhnetal.,2005;Wein-
berger et al., 2006). These exaggerated beta oscillations are re-
duced during voluntary movements (Amirnovin et al., 2004;
Kuhn et al., 2004; Williams et al., 2005) and are attenuated, to-
gether with motor symptoms, by dopamine-replacement thera-
pies (Brown et al., 2001; Levy et al., 2002; Williams et al., 2002;
Priori et al., 2004; Kuhn et al., 2006). Furthermore, electrical
stimulation of STN at beta frequencies, which artificially induces
excessivebetaactivitysynchronization,promotesbradykinesiain
patients(Chenetal.,2007).Theseclinicalstudiessuggestthat,by
inappropriately coordinating neuronal activities, exaggerated
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Once established, excessive beta oscillations can be effectively
“filtered out” by acute pharmacological therapies, but this does
not necessarily mean they arise from acute loss of dopaminergic
frequency filtering rather than slower long-term adaptations.
ThisissueisnotjustimportantforunderstandingPDpathophys-
iology; any dependence on continuing plasticity might offer cru-
cial new targets for disease-modifying interventions. However,
dissecting the mechanisms underlying pathologically synchro-
nized beta oscillations is challenged by clinical constraints, and
becausetheseactivitieshavenotbeenparticularlyforthcomingin
animal models. Indeed, although animal models of PD have es-
tablishedthecentraltenetthatdopaminemodulatesbasalganglia
and cortical activities in the frequency domain, most studies em-
phasize the emergence of pathologically synchronized oscilla-
tionswithfrequenciesof15Hz(Bergmanetal.,1998;Boraudet
al.,2005;Gatevetal.,2006;Hammondetal.,2007),i.e.,substan-
tially lower frequencies than those recorded clinically. We have
shown previously, however, that 6-hydroxydopamine (6-
OHDA) lesions of dopamine neurons, a well established rat
model of PD (Schwarting and Huston, 1996a,b), significantly
increases beta oscillations in local field potentials (LFPs) re-
corded from the STN and cortex (Sharott et al., 2005). Here, we
define the neural basis of abnormal beta oscillations using this
clinically relevant chronic PD model, and test whether acute dis-
ruption of dopamine transmission provokes their emergence.
MaterialsandMethods
ExperimentalprocedureswereperformedonadultmaleSpragueDawley
rats (Charles River, Margate, UK), and were conducted in accordance
with the Animals (Scientific Procedures) Act, 1986 (United Kingdom),
and with Society for Neuroscience Policies on the Use of Animals in
Neuroscience Research.
Electrophysiologicalrecordingsinanesthetizedrats.Recordingsweremade
in eight dopamine-intact control rats (288–366 g) and nine chronically
6-OHDA-lesioned rats (309–411 g at the time of recording). Anesthesia
was induced with 4% v/v isoflurane (Isoflo; Schering-Plough, Welwyn
Garden City, UK) in O2, and maintained with urethane (1.3 g/kg, i.p.;
ethylcarbamate;Sigma,Poole,UK)andsupplementaldosesofketamine
(30 mg/kg, i.p.; Ketaset; Willows Francis, Crawley, UK) and xylazine (3
mg/kg, i.p.; Rompun; Bayer, Leverkusen, Germany) as described previ-
ously(Magilletal.,2001,2006).Allwoundmarginswereinfiltratedwith
the local anesthetic, bupivacaine (0.75% w/v; Astra, Kings Langley, UK).
Animals were then placed in a stereotaxic frame (Kopf, Tujunga, CA).
Body temperature was maintained at 37  0.5°C using a homeothermic
heating device (Harvard Apparatus, Edenbridge, UK). Electrocortico-
grams (ECoGs), electrocardiographic activity, and respiration rate were
monitored constantly to ensure the animals’ well being (Magill et al.,
2006). The ECoG was recorded via a 1-mm-diameter steel screw juxta-
posedtotheduramaterabovetherightfrontal(somaticsensory–motor)
cortex (4.5 mm anterior and 2.0 mm lateral of bregma) (Paxinos and
Watson, 1986), and was referenced against another screw implanted in
the skull above the ipsilateral cerebellar hemisphere. The raw ECoG was
bandpass filtered (0.3–1500 Hz, 3 dB limits) and amplified (2000;
DPA-2FS filter/amplifier; Scientifica, Harpenden, UK) before acquisi-
tion.ExtracellularrecordingsofunitactivityandLFPsinandaroundthe
STN were simultaneously made using “silicon probes” (NeuroNexus
Technologies, Ann Arbor, MI). Each probe had 16 recording contacts
arranged in a single vertical plane, with a contact separation of 100 m.
Each contact had an impedance of 0.9–1.3 M (measured at 1000 Hz)
and an area of 400 m
2. The same probe was used throughout, but it
was cleaned after each experiment in a proteolytic enzyme solution
(Magill et al., 2006). This was sufficient to ensure that contact imped-
ances and recording performance were not altered by probe use and
reuse. Monopolar probe signals were recorded using high-impedance
operationalamplifiers(AdvancedLinCMOS;TexasInstruments,Dallas,
TX) and were referenced against a screw implanted above the contralat-
eralcerebellum.Afterpreamplification,extracellularsignalswerefurther
amplified (1000–2000) and low-pass filtered (0–6000 Hz) using pro-
grammable differential amplifiers (Lynx-8; Neuralynx, Tucson, AZ). In
anothertwountreatedcontrolrats(325and350g)andthreechronically
6-OHDA-lesioned rats (370–433 g at time of recording), recordings of
unit activity in STN (but not LFPs) were made using glass electrodes
instead of silicon probes, according to standard methods (Magill et al.,
2001). Briefly, extracellular recordings of the action potentials of STN
neuronsweremadeusing15–25Mglasselectrodes(tipdiameter,1.5
m), which contained saline solution (0.5 M NaCl) and Neurobiotin
(1.5%w/v;VectorLaboratories,Peterborough,UK).Glasselectrodesig-
nals were amplified (10) through the active bridge circuitry of an
Axoprobe-1A amplifier (Molecular Devices, Sunnyvale, CA), AC-
coupled, amplified an additional 100, and then bandpass filtered at
300–5000 Hz (DPA-2FS; Scientifica). The ECoG and probe/glass elec-
trode signals were each sampled at 17.5 kHz on-line using a Power1401
Analog-DigitalconverterandaPCrunningSpike2acquisitionandanal-
ysis software (Cambridge Electronic Design, Cambridge, UK). The re-
cording strategy was to place three probe contacts within the STN. The
STN was identified on-line by comparison of recorded unit activity with
the known characteristic discharges of STN neurons under slow-wave
activity (SWA) in urethane anesthesia (Magill et al., 2001). Neurons are
more active and more densely packed in STN compared with neighbor-
ing structures. Thus, probe contacts within STN tended to register more
intense multiunit activity (see Figs. 1F,2 E). The recording of LFPs
evoked by bipolar electrical stimulation of the ipsilateral frontal cortex
allowed unequivocal targeting of the STN on-line (Magill et al., 2004).
Finally, all recording locations were additionally verified after the exper-
iments using standard histological procedures (Magill et al., 2006). Ac-
tivity was recorded first during SWA, which accompanies deep anesthe-
sia and is similar to activity observed during natural sleep, and second
duringepisodesof“globalactivation,”whichcontainpatternsofactivity
that are more analogous to those observed during the awake, behaving
state (Steriade, 2000). Transition from SWA to activation is exemplified
by obliteration of the cortical slow oscillation (1 Hz), as well as  (1–4
Hz) and spindle (7–14 Hz) oscillations (Steriade, 2000). Notably, the
neuronal activity patterns present under this anesthetic regimen may
onlybequalitativelysimilartothosepresentintheunanesthetizedbrain.
Nevertheless, the urethane-anesthetized animal still serves as a useful
model for assessing the impact of extremes of brain state on functional
connectivity within and between the basal ganglia and cortex (Magill et
al., 2006). Sensory stimulation and subsequent global activation were
elicited by pinching the hindpaw for 10–15 s with serrated forceps that
were driven by a standard pneumatic pressure, as described previously
(Magill et al., 2006). The animals did not exhibit either a marked change
in ECG or respiration rate, and did not exhibit a hindpaw withdrawal
reflex, in response to the pinch. Moreover, withdrawal reflexes were not
present during episodes of spontaneous and/or prolonged global activa-
tion, thus indicating anesthesia was adequate throughout recordings.
Dopaminereceptorantagonists.Toachieveacuteandwidespreadphar-
macologicaldisruptionofdopaminetransmission,ratsreceivedsystemic
injectionsofpotentandselectiveantagonistsofdopamineD1-likerecep-
tors [R()-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-
1H-3-benzazepine (SCH-23390), 0.5 mg/kg, s.c.; Sigma] and D2-like
receptors [3,5-dichloro-N-(1-ethylpyrrolidin-2-ylmethyl)-2-hydroxy-
6-methoxybenzamide [S()-raclopride], 2 mg/kg, i.p.; Sigma]. Both
drugs were dissolved in physiological saline solution and administered
within 10 s of each other. Antagonists and doses were selected according
to previous behavioral observations (Degos et al., 2005).
6-Hydroxydopamine lesions of dopamine neurons. Unilateral 6-OHDA
lesions were performed on 213–293 g rats, as described previously
(Magilletal.,2001).Twenty-fiveminbeforetheinjectionof6-OHDA,all
animals received a bolus of desipramine (25 mg/kg, i.p.; Sigma) to min-
imizetheuptakeof6-OHDAbynoradrenergicneurons(Schwartingand
Huston,1996a).Anesthesiawasinducedandmaintainedwithisoflurane
(as above). The neurotoxin 6-OHDA (hydrochloride salt; Sigma) was
dissolved immediately before use in ice-cold 0.9% w/v NaCl solution
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Then, 3 l of 6-OHDA solution was injected into the region adjacent to
the medial substantia nigra (4.5 mm posterior and 1.2 mm lateral of
bregma, and 7.9 mm ventral to the dura) (Paxinos and Watson, 1986).
Theextentofthedopaminelesionwasassessed14or15dafter6-OHDA
injection by challenge with apomorphine (0.05 mg/kg, s.c.; Sigma)
(SchwartingandHuston,1996b).Thelesionwasconsideredsuccessfulin
those animals that made 100 net contraversive rotations in 20 min
(Magill et al., 2001). Note that the emergence of exaggerated beta oscil-
lations is not dependent on apomorphine (Sharott et al., 2005). Electro-
physiological recordings were performed ipsilateral to 6-OHDA lesions
in anesthetized rats 21–35 d after surgery, when pathophysiological
changes in the basal ganglia are likely to have leveled out near their
maxima (Vila et al., 2000).
Electrophysiological recordings in behaving rats. Dopamine-intact rats
(260–373g;n5)wereanesthetizedwithisofluraneandimplantedwith
a screw above the frontal cortex for subsequent ECoG recordings (as
above). Behavioral monitoring, electrophysiological recordings, and an-
tagonist administration were performed 8–10 d after implantation sur-
gery. The ECoGs were referenced against a screw implanted centrally
abovethecerebellum,andbandpassfiltered(0.1–3000Hz)andamplified
(1000; EPA-6 amplifier; Sensorium, Charlotte, VT) before acquisition
at 20 kHz. The induction of catalepsy, defined as the delayed or absent
correction of an abnormal positioning of the extremities, was tested
10–15 min after administration of SCH-23390 and raclopride using a
standard bar test (Degos et al., 2005). None of the animals were able to
retract their forepaws from the raised horizontal bar (10 cm above the
floor) and correct their unusual posture within 1 min of paw placement;
thus,allwereconsideredfullycataleptic(Degosetal.,2005).Forrecord-
ings in behaving lesioned subjects, rats (215–246 g; n  5) were anesthe-
tizedwithisoflurane,unilaterallyinjectedwith6-OHDA,andimplanted
withascrewabovetheipsilateralfrontalcortexinasinglesurgicalsession
(asabove).RecordingsofECoGswereperformedbetween3:00P.M.and
6:00P.M.(reversedlight/darkcycle:lightson8:00A.M.to8:00P.M.)on
postoperative days 1, 4, and 15, and care was taken to record when the
animalswerefullyalertbutimmobile,behaviorknowntofavortheemer-
gence of abnormal beta oscillations (Sharott et al., 2005). Lesioned rats
were confirmed as such by apomorphine challenge (see above).
Data analysis. Epochs of robust cortical slow-wave activity or global
activationwereselectedaccordingtothepreviouslydescribedcharacter-
istics of these brain states (Magill et al., 2001, 2006). Frequency analyses
wereperformedon100.10.1s(meanSEM)and94.82.3sofdata,
100.1  0.1 and 97.2  2.8 s of data, and 100.1  0.1 and 88.8  7 . 4so f
data recorded during robust SWA and during activation in chronically
lesioned, untreated control, and antagonist-treated control animals, re-
spectively. Recordings of LFPs and ECoGs were low-pass filtered at 100
Hzanddown-sampledto250Hzoff-lineinSpike2foranalysispurposes.
Frequency-domain (spectral) analyses were performed in Matlab v6.0
(The MathWorks, Natick, MA) using a mixed-radix algorithm. Spectra
were estimated by dividing the data epochs into a number of disjoint
sections of 1 s duration. Frequency resolution was 1 Hz. Data were win-
dowed with a Hanning filter to control “spectral leakage.” In the main
analysis of STN-LFPs, we averaged the power from each of three probe
contacts in STN, and compared this across brain states and treatment
groups. In a subsidiary analysis, this average of STN-LFP power was
comparedwiththeLFPpowerseparatelyaveragedacrossthetwonearest
probe contacts above and below STN in each animal. We also analyzed
the linear phase/amplitude relationships (as defined by coherence) and
mutualinformationbetweenSTNsignalsthatweremaximallyrepresen-
tative of activity in local regions of the STN in the different groups. Our
original monopolar LFPs were not suitable for this, and we could not
extract a sufficient number of bipolar LFPs because, on average, we had
only three probe contacts in each STN. Accordingly, we sought evidence
of elevated synchronization across regions of the STN using multiunit
signalsfromeachprobecontact(seeFigs.1F,2E).Themultiunitactivity
was derived by high-pass filtering the wideband probe signals at 500 Hz
off-line(Spike2),andconvertingtheanalogsignalintoapointprocessby
considering those data points that exceeded the mean 3S Do ft h e
analog signal. The coherence between point process data representing
multiunitactivityateachprobecontactintheSTNwasthendetermined
using previously published methods (Halliday et al., 1995) and software
(Neurospec version 1.0; www.neurospec.org). Data were divided into
blocks of 8192 data points, affording a frequency resolution of 2.18 Hz.
Lower-bound estimates of the mutual information between STN sites
were derived from the coherence, as described previously (Borst and
Theunissen, 1999). Before performing our analyses of coherence and
mutual information between multiunit activities recorded at different
STN sites, we first assessed the analog signals (see above) for the possi-
bility of coregistration of the same unit(s) across contact pairs because
suchcontaminationmightconfoundestimatesofcoherence.Coregistra-
tionofthesameunit(s)wouldbereflectedaslarge,butnarrow,symmet-
ricalandcentrallyalignedpeaksincross-correlograms(1msbins)ofthe
analog signals. Thus, in the absence of signal contamination, activity
countsinthecentralcross-correlogrambinshouldbesimilartocountsin
flanking bins. We rejected 4 of 27, 3 of 24, and 3 of 24 signal pairs from
lesioned animals, untreated controls, and antagonist-treated controls,
respectively, where the cross-correlogram bin centered at t  0m sh a d
35% of the mean count in the flanking two bins on either side. This
narrow total sampling period of 5 ms was necessary to ensure relative
local stationarity, even in the presence of the biological synchronization
predicted in lesioned animals (where oscillatory temporal interactions
werelikelytooccurwithaperiodof50ms).Themeanexcesscountsin
the central bins of the remaining cross-correlograms did not differ from
unity, suggesting negligible contamination (4  3% and 6  3% above
flanking bins for lesioned animals and untreated controls, respectively,
and 6  4% below flanking bins for antagonist-treated controls; all p 
0.05, one-sample t tests; median of all excess counts was 1% above mean
countinflankingbins).Finally,autocorrelograms(2msbins)andspike-
triggered LFP averages were constructed using standard procedures in
Spike2, and Lomb periodograms of spike trains (0.5–100 Hz range) ac-
cording to previous publications (Magill et al., 2001).
Statistical testing. For analysis of recordings in anesthetized animals,
powervalueswerenormalizedbylogarithmictransformationbeforesta-
tisticaltesting(Hallidayetal.,1995).Transformedpowerdatawerenor-
mally distributed, as judged by the single-sample Kolmogorov–Smirnov
test and p  0.05 to reject (SPSS; SPSS, Chicago, IL). To determine
whetherpowerinthebetabandwasgreatestintheSTN-LFPsandECoGs
after6-OHDAlesions,incontrolanimalsorafterantagonisttreatmentof
control animals, we used combinations of two-tailed unpaired and
paired t tests (corrected for multiple comparisons) (see below). Because
analyzing data from these three groups involved a comparison of paired
data(i.e.,untreatedcontrolsvstreatedcontrols)andcomparisonofthese
data with a third group that was not paired (lesioned animals), this
combination of t tests was more suitable than either a standard ANOVA
or repeated-measures ANOVA. Equality of variances was assessed using
Levene’s test ( p  0.05 to reject). Where ANOVAs were performed for
other multiple group comparisons, Mauchly’s test was used to confirm
thesphericityofthedataand,whennonspherical,aGreenhouse-Geisser
correction performed. All tests specified in the text remained significant
atp0.05aftercorrectionsformultipletestingusingthefalsediscovery
rate procedure (Curran-Everett, 2000), unless otherwise stated. Means
andcorrespondingSEMsaregiveninthetextandillustrations.Forcom-
parisons of ECoG data from behaving control animals before and after
saline or antagonist administration (100 s per treatment per animal), we
usedaone-wayrepeated-measuresANOVA,withposthocBonferroni’st
tests for multiple comparisons with the control group (SigmaStat; Systat
Software, London, UK). For comparisons of ECoG data from behaving
lesioned animals (100 s per day per animal), which had smaller sample
sizes, we used nonparametric statistical testing because some data sets
were not normally distributed ( p 	 0.05; Kolmogorov–Smirnov test).
We thus used Friedman’s repeated-measures ANOVA on ranks (more
suitablethanstandardANOVAsforassessingnonparametricdata),with
Student–Newman–Keuls tests for post hoc pairwise multiple compari-
sons (SigmaStat). The Mann–Whitney rank sum test was used for com-
parisons with unpaired nonparametric data, i.e., between control and
lesionedanimals.Mediansandcorrespondingquartilesareshowninthe
figures where appropriate.
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Pathologicalbetaoscillationsaredependentondopamine
lossandbrain state
Akeyaimofthisstudywastodefinetheneuralbasisofabnormal
betaoscillationsincortico-STNcircuits.Itwasthusimportantto
simultaneously detect the synchronized activity of local popula-
tions of neurons in and around STN. Our strategy was to sample
both single-unit and multiunit activity and LFPs using linear
arrayswithmultiple,spatiallydefinedrecordingcontacts(silicon
probes) (Magill et al., 2006). The STN is not only small (	 0.1
mm
3)butitisalsolocateddeep(7.5–8mm)intheadultratbrain
(Oorschot, 1996), which greatly challenges the use of these re-
cording arrays in behaving rodents. We thus chose to make our
initial analyses in anesthetized animals, which had the additional
importantbenefitofallowingustorecordwiththeprobesduring
two well defined and controlled brain states, slow-wave activity
and global activation (Magill et al., 2006). The former state is
dominated by low-frequency rhythms (10 Hz) and is qualita-
tivelysimilartonaturalsleep,whereasthelattercontainspatterns
ofactivitythataremoreanalogoustothoseobservedduringwak-
ing behavior (Steriade, 2000). Hence, we could define any inter-
action between gross brain state and the emergence of patholog-
ical synchrony. However, because pathological beta oscillations
are expressed in alert PD patients, but have not been studied in
anesthetizedsubjects,ourfirstprioritywastoestablishmeaning-
ful parallels between clinical data and our experimental
paradigm.
We recorded epidural ECoGs from the frontal cortex, as well
asactivityatmultiplesitesinandaroundtheSTN,inanesthetized
dopamine-intact control rats (n  8) and unilaterally 6-OHDA-
lesioned rats (n  9) during SWA and global activation. Sponta-
neous or sensory-driven transitions from SWA to global activa-
tion were accompanied by the emergence of prominent beta
oscillations (15–25 Hz) in ECoGs and STN-LFPs recorded from
6-OHDA-lesioned animals (Fig. 1A–C), but not those recorded
from control animals (Figs. 1C, 2). The prevalent frequencies of
these abnormal beta oscillations in cortex and STN were similar
across all 6-OHDA-lesioned animals, with an average peak fre-
quency of around 20 Hz (see Figs. 1, 4A,5 A). Thus, chronic
6-OHDA lesions of dopamine neurons profoundly exaggerate
beta oscillations in field activity recorded from cortex and STN
during the activated brain state but not during SWA. Moreover,
the beta oscillations evident in cortical and STN field activities in
ourratmodelofPDcomparefavorablywithpreviousfindingsin
PD patients.
Having validated our experimental paradigm, we next ad-
dressed a key question: what is the neural basis and functional
significance of these pathological beta oscillations? Cortical field
activity, such as the ECoG, likely reflects the synchronized sub-
threshold activities and, to a lesser extent, suprathreshold activi-
ties of populations of principal neurons. Similar inferences have
been made for LFPs recorded in the basal ganglia (Boraud et al.,
2005), but the irregular, nonlaminated architecture of the STN
makes interpretation of STN-LFPs more difficult. Prominent
betaoscillationsinLFPswerelargelyrestrictedtoSTN,compared
with immediately above or below STN (Fig. 1C), suggesting a
direct link between the recorded LFPs and STN neuron activity.
We quantitatively tested for the focal expression of beta oscilla-
tions in STN (compared with the neighboring ventral zona in-
certa and cerebral peduncle) after averaging LFP power across
frequencies, probe recording contacts in or around STN, and
acrosslesionedanimalsduringtheactivatedbrainstate.Here,we
averaged power across 17–23 Hz, thus concentrating on those
frequency bins underlying the peak of beta activity in lesioned
animals (see Figs. 1, 4A). Henceforth, for convenience, we will
refer to this frequency range as the “peak beta” (p) band. A
one-wayANOVAconfirmedposition[threelevels;“aboveSTN”
(in the ventral zona incerta, 	200 m from dorsal STN border),
“withinSTN,”and“belowSTN”(inthecerebralpeduncle,	200
m from the ventral STN border)] as a main effect ( p  0.002).
Post hoc paired t tests confirmed that the LFP power in the p
band in STN (mean log power, 2.766  0.033) significantly ex-
ceeded that immediately above STN (2.617  0.022; p  0.002)
and below STN (2.643  0.023; p  0.001).
The focality of the exaggerated beta oscillations in STN-LFPs
suggests they are generated by events in local ensembles of STN
neurons. To gain further insights into the neural basis of these
pathological rhythms, we also studied the simultaneously re-
corded single-unit and multiunit activities. In lesioned rats, sin-
gleSTNneurons(n24;ofwhich14wererecordedwithprobes,
and10withglasselectrodes)typicallyfiredeitherburstsofspikes
or single spikes in time with many, but not necessarily all, cycles
of the beta oscillations in LFPs (Fig. 1D,E). Accordingly, the
spike trains of most STN neurons (14 of 24) contained a signifi-
cant oscillatory component at 20 Hz (Fig. 1G), and significant
coherence between single units and STN-LFPs peaked at similar
beta frequencies (Fig. 1H). Rhythmic beta activity was not re-
stricted to single STN neurons and, indeed, beta LFP oscillations
were also reflected in periodic grouped discharges of multiunits
within STN, but not immediately above or below STN (Fig. 1F).
Importantly, and in keeping with LFP data, these characteristic
single-unit and multiunit activities were not seen in the STN of
control rats (Fig. 2). The spike trains of 6 of 18 STN neurons
recorded in control rats (eight neurons recorded with probes, 10
withglasselectrodes)containedsignificantoscillations,butthese
oscillations were outside the beta band (Fig. 1G). Coherence be-
tween single units and STN-LFPs in control rats did not peak at
beta frequencies, and unit/LFP coherence in the p band was
significantly higher in lesioned rats compared with control rats
(Fig. 1H). Moreover, on average, STN neurons in lesioned rats
fired significantly faster than those in control rats (Fig. 1I). In
lesioned animals, the mean firing rate of STN neurons that ex-
hibited significant beta oscillations in their spike trains was sim-
ilar to the mean firing rate of STN neurons that did not oscillate
(34.0  3.4 Hz and 29.5  3.7 Hz, respectively; p  0.4). For
oscillating neurons, there was no clear relationship between the
power of the spike train oscillation (as measured in the Lomb
periodogram) and firing rate (R
2  0.13; p  0.19). In control
animals,oscillatorySTNneuronsexhibitedsimilarfiringratesto
nonoscillatory STN neurons (13.8  2.7 Hz and 14.6  2.0 Hz,
respectively; p  0.8). Together, these data suggest that, after
6-OHDA lesions, populations of STN neurons tend to engage in
synchronized oscillatory firing at beta frequencies during the ac-
tivated state, and that the postsynaptic membrane currents un-
derlying this striking activity also summate in time and space to
generate beta oscillations in STN-LFPs.
Pathologicalbetasynchronizationisspatiallydistributedand
affectsinformationcodingwithin STN
The focal increases in p power of STN-LFPs in chronically
lesioned animals during global activation could arise through
increased oscillatory activity of STN neurons in a local net-
work of fixed size (together with a tighter temporal locking of
oscillatory activity across that network) and/or through a spa-
tialextensionofanoscillatingnetworktorecruitmoredistrib-
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oscillatoryactivityatthelevelofsingleSTNneurons(Fig.1G),
thus providing some evidence supporting the former.
Whether the latter also occurred was explicitly addressed by
testing for increased coherence in the p band between sites
withinSTNinthelesionedanimalsrelativetocontrols.Tothis
end, we wanted electrical signals that were maximally repre-
sentativeofactivityinlocal(restrictedto	100m)regionsof
Figure1. Exaggeratedbetaoscillationsarepresentinthecortexandsubthalamicnucleusof6-OHDA-lesionedanesthetizedrats.A,FrontalECoGsandtime-evolvingpowerspectrogramofECoG
activity.Exaggeratedbetaoscillationsemergeduringspontaneousactivation(2)butnotSWA(1).Calibration:0.2mV,500ms.a.u.,Arbitraryunits.B,Spectrogramsofsimultaneouslyrecorded
activityincortex(ECoG)andsubthalamicnucleus(STN-LFP)duringspontaneousactivation.Weakpowerat50Hzislinenoise.C,Powerspectra(Power)ofECoGs,aswellasLFPssimultaneously
recordedfromwithin,immediatelyaboveandbelowtheSTN,inarepresentativelesionedandcontrolanimalduringactivation.Grayboxesindicatetheclassicbetaband(15–30Hz).D,E,Beta
oscillationsareevidentinthedischargesofsingleSTNunits,asshowninautocorrelograms(AC)andperiodograms(Lomb).Thedashedlineinperiodogramindicatesp0.05.STNneuronsfireeither
spikeburstsorsinglespikesintimewithmost(butnotall;arrowheadinE)betacyclesinoscillatoryLFPs,asshowninspike-triggeredLFPaverages(STAv).PowerspectraofECoGandSTN-LFP
simultaneouslyrecordedwithneuroninDarealsoshown.Calibration:D,0.2mV(ECoG),0.5mV(unit),0.1mV(LFP),100ms;E,0.125mV,100ms.F,Betaoscillationsarealsoreflectedinrhythmic
multiunitactivityinSTN(contacts2–4),butnotimmediatelyaboveorbelow(contacts1and5).Traces1–5ofunitsandLFPswererecordedsimultaneously.Calibration:0.1mV,100ms.G,Plotof
STNneuronswithsignificantoscillationsintheirspiketrains(thoserecordedwithsiliconprobesorglasselectrodesarerepresentedbydiamondsandcircles,respectively).H,Coherence(left)and
totalbetacoherenceat17–23Hz(right)betweensingleunitsandLFPsintheSTNasrecordedwithprobes(n14and8unit/LFPpairsinlesionedandcontrol,respectively).Thedashedlineisthe
95%confidencelimit.Dataaremeans1SEM.*p0.005.I,MeanfiringratesofSTNneuronsduringactivatedbrainstate.Dataaremeans1SEM.*p	0.001.DatainA–Farefromdifferent
lesionedanimals.
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nopolar LFPs recorded from each probe contact. There was a
significant increase in coherence between multiunit activities
recorded across STN sites (up to 300 m apart) in chronically
lesioned animals, compared with controls, and again, this co-
herence peaked at 20 Hz, and was limited to the p band
(Fig. 3A,B). The functional significance of this increased beta
synchronization within STN may lie in the accompanying in-
crease in the shared or mutual information coded by neurons
in different regions of STN. Within the information theory
framework, the total information capacity of a set of process-
ing elements is related to the sum of the entropies of the
individual elements less an amount that corresponds to the
mutual information between elements. To quantify this, we
derived lower-bound estimates of mutual information from
the coherence between sites in the STN. There was an increase
in the mutual information between sites in the STN of chron-
icallylesionedanimalscomparedwithuntreatedcontrols(Fig.
3C). Thus, in 6-OHDA-lesioned rats, pathological beta oscil-
lationsinSTN-LFPsreflectexcessiveanddistributedsynchro-
nization of activity at similar frequencies between neurons,
which may diminish the information coding capacity of pro-
cessing channels within STN.
Onlychronicdisruptionofdopaminetransmissionincreases
betaoscillationsinSTN-LFPs
How then does this pathological network state arise and become
established? Are exaggerated beta oscillations the product of
slowly evolving chronic adaptations to dopaminergic denerva-
tion, or is the acute disruption of dopamine transmission a suf-
Figure2. Betaoscillationsarenotprevalentinthecortexandsubthalamicnucleusofdopamine-intactanesthetizedrats.A,FrontalECoGsandtime-evolvingpowerspectrogramofECoGactivity
inacontrolanimal.Neitherglobalactivation(2)norSWA(1)brainstateswereassociatedwithprominentbetaoscillations.B,Spectrogramsofsimultaneouslyrecordedactivityinthecortex(ECoG)
andsubthalamicnucleus(STN-LFP)duringspontaneousactivation.Weakpowerat50Hzislinenoise.C,Powerspectra(Power)ofECoGsaswellasLFPssimultaneouslyrecordedfromwithin,
immediatelyabove,andbelowSTN,inarepresentativecontrolanimalbeforeandaftersystemictreatmentwithD1andD2receptorantagonists(SCH-23390at0.5mg/kgandracloprideat2mg/kg).
Grayboxesindicatetheclassicbetaband(15–30Hz).D,Duringactivationincontrolanimals,thedischargesofsingleSTNunitswerenotclearlyperiodic,asshownbyflatautocorrelograms(AC)and
periodograms(Lomb).Spike-triggeredLFPaverages(STAv)werecorrespondinglyflat.ThepowerspectraofECoGandSTN-LFPsimultaneouslyrecordedwiththeneuroninDarealsoshown.E,
SimultaneousrecordingsofmultiunitactivityandLFPsintheSTN(contacts2–5),aswellasimmediatelyaboveandbelowtheSTN(contacts1and6,respectively)ofacontrolrat.Calibrationsare
thesameasinFigure1,exceptinD:0.1mV(unit).
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dopamine-intact anesthetized control rats before and after sys-
temic treatment with selective antagonists of dopamine D1-like
receptors (SCH-23390; 0.5 mg/kg, s.c.) and D2-like receptors
(raclopride; 2 mg/kg, i.p.). Group power spectra of STNLFPs
averaged across recording contacts within STN and across ani-
malsshowedthat,duringtheactivatedbrainstate,adiscretepeak
in beta activity was only present in chronically lesioned animals,
andthatthispeakcenteredaround20Hz(Fig.4A).Accordingly,
duringglobalactivation,chronicallylesionedanimalshadsignif-
icantly more p LFP power in STN than untreated controls (Fig.
4C)(p  0.002, unpaired t test) or antagonist-treated controls
( p  0.001). Acute blockade of dopamine transmission in con-
trol animals did not result in the emergence of a distinct peak in
beta activity, and there was no difference between STN-LFPs
recorded before and after antagonist treatment in control ani-
mals (Figs. 2C,4A,C)(p  0.322). Moreover, during SWA, dis-
tinctbetapeakswerenotpresentinSTN-LFPs,andpLFPpower
was similar between the three experimental groups (Fig. 4B,D)
( p0.1forallcomparisons).Insummary,chronicbutnotacute
disruption of dopamine transmission significantly potentiates
beta oscillations in the STN, and this effect is restricted to the
activated brain state. However, dopamine receptor blockade did
affect activities at other frequencies. During global activation,
acutedisruptionofdopaminetransmissionsuppressedSTN-LFP
power across 26–48 Hz, and consequently, in this low gamma
frequency band, treated control animals had significantly less
activity than lesioned and untreated control animals (Fig. 4A)
(log power suppressed to 96 and 97% of lesioned and untreated
controls;bothp	0.02,unpairedandpairedttests,respectively).
Onlychronicdisruptionofdopaminetransmissionincreases
betaoscillationsin ECoGs
Group power spectra of frontal ECoGs averaged across animals
showed that, during the activated brain state, a discrete peak in
beta activity was again confined to chronically lesioned animals,
and that this peak also centered around 20 Hz (Fig. 5A). During
global activation, chronically lesioned animals had significantly
more p ECoG power than untreated controls (Fig. 5C)(p 
0.002,unpairedttest)orantagonist-treatedanimals( p0.001).
There was no difference between ECoGs recorded before and
after antagonist treatment in control animals (Figs. 2C,5 A,C)
( p  0.5, paired t test). Furthermore, during SWA, distinct beta
peakswerenotpresent,andECoGpowerwassimilarbetweenthe
three experimental groups (Fig. 5B,D)
( p  0.38 for all comparisons). In short,
potentiation of cortical beta oscillations
was restricted to chronically lesioned ani-
mals in the activated state, and therefore
paralleledchangesintheSTN.Yet,asinthe
STN, dopamine receptor blockade was not
without some effects. During activation,
acute disruption of dopamine transmis-
sion suppressed ECoG activity across
26–48Hz,suchthatbothlesionedanimals
and untreated controls had significantly
more activity than treated controls within
this low gamma frequency band (Fig. 5A)
(log power suppressed to 95% of lesioned
and untreated controls, both p  0.01,
paired and unpaired t tests, respectively).
Thus, dopamine receptor blockade in-
duced similar changes in cortical and STN
gamma activity.
Differences in p power of STN-LFPs and ECoGs between
experimental groups were not caused by relatively greater brain
activation in chronically lesioned animals. Indeed, reductions of
slow wave (1–2 Hz) ECoG power during global activation were
similar in chronically lesioned animals, untreated controls, and
antagonist-treated controls (mean log powers, 0.585  0.080,
0.515  0.037, and 0.520  0.055; p  0.5 for all compari-
sons). In summary, the exaggeration of beta oscillations in STN-
LFPs and ECoGs in the activated state in chronically 6-OHDA-
lesioned animals was unlikely to have simply resulted from an
acuteresponsetoreduceddopaminetransmissionbecauseitwas
absent in control animals treated with receptor antagonists dur-
ing comparable degrees of brain activation.
PredictabilityofD1/D2antagonistactionsin
anesthetized animals
To ensure that the failure of the receptor antagonists to induce
exaggerated beta oscillations did not result from unpredicted or
compromised drug actions under the anesthetic regimen used
here, we tested the effects of antagonist administration on mid-
brain dopamine neurons. The activity of these neurons is partly
controlled by local and extrinsic dopamine receptors, so they act
as robust “biosensors” of agonist/antagonist actions. Indeed, ac-
tivation of receptors with the mixed D1/D2 receptor agonist apo-
morphine decreases the firing of dopamine neurons (Bunney et
al.,1973),whereasacuteblockadeofD1orD2receptorsincreases
theiractivity(Carlsonetal.,1986;PucakandGrace,1994;Mereu
et al., 1995). We performed in vivo extracellular recordings of
identified dopamine neurons (n  3) in anesthetized animals
(n  3) during acute drug treatments. As expected, systemic
administration of apomorphine (0.05 mg/kg, s.c.) led to a pro-
longed reduction in the activity of all dopamine neurons, which
was consistently and rapidly attenuated by coadministration of
SCH-23390 and raclopride (supplemental Fig. 1, available at
www.jneurosci.org as supplemental material). Antagonist treat-
ment also led to an increase in spontaneous activity, and the
effects of a subsequent dose of apomorphine were blocked (sup-
plemental Fig. 1, available at www.jneurosci.org as supplemental
material). Together, these data indicate that, under this anes-
thetic regimen, SCH-23390 and raclopride effectively blocked
dopamine receptors in the brain, and thus, acted as predicted.
Figure3. Temporalcouplingandmutualinformationofmultiunitactivitiesinthesubthalamicnucleusincreaseafter6-OHDA
lesions.A,AveragecoherencespectraofSTNmultiunitactivitiesrecordedinuntreatedcontrolanimals(n21contactpairs),
controlsafteracuteantagonisttreatment(n21contactpairs,“treatedcontrols”),andchronicallylesionedanimals(n23
contact pairs). The gray box indicates the beta band (17–23 Hz) used in quantitative analyses. B, Average coherence of STN
activitiesatbetafrequencies(17–23Hz)acrossexperimentalgroups.Dataaremeans1SEM.*p	0.05.C,Mutualinformation
betweensiteswithintheSTN.Dataaremeans1SEM.*p	0.05.
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dopaminetransmissioninbehaving animals
Chronic 6-OHDA lesions, but not acute treatment with selective
D1 and D2 antagonists, reliably exaggerated beta oscillations in
the frontal cortex of anesthetized animals. To further test the
possibility that anesthesia might have occluded antagonist ac-
tions on beta activity, we recorded frontal ECoGs in behaving
dopamine-intact animals before and after antagonist treatment
(n  5 rats) (Fig. 6A–C). As shown previously (Degos et al.,
2005),systemiccoadministrationofSCH-23390(0.5mg/kg)and
raclopride(2.0mg/kg)inducedseverecatalepsy,withanonsetof
10–15 min to a full-blown cataleptic state (Fig. 6C). However,
despite this profound behavioral effect, antagonist treatment did
notproduceanexaggeratedpeakinECoGpoweratbetafrequen-
cies (Fig. 6B). The peak frequency of abnormal beta oscillations
previously recorded in behaving lesioned animals was 25–26 Hz
(Sharott et al., 2005) (Fig. 6D), which is slightly higher than
oscillationspresentduringanesthesia.Thus,forstatisticaltesting,
thefrequencybandanalyzedwasshiftedhigherandwider(19–31
Hz) than that analyzed in anesthetized animals to safely accom-
modate the predicted peak frequency of beta oscillations during
behavior. Quantitative analyses confirmed that neither antago-
nist nor saline vehicle treatment augmented cortical beta oscilla-
tions above untreated control levels (Fig. 6B,C) [two control
periods combined, two saline periods combined, and two antag-
onistperiods(at20and25min)werecombinedforanalysis].
Instead,duringcatalepsy,therewasasmallbutsignificantreduc-
tion in beta power compared with controls (power in controls
and antagonist treated, 3.03  0.15  10
4 mV
2 and 2.77 
0.24  10
4 mV
2, respectively; p  0.02, one-way repeated-
measures ANOVA and Bonferroni’s t test). Together with our
control studies of dopamine neurons, these experiments in be-
havinganimalsdemonstratethattheinabilityofacutedopamine
receptor blockade to exaggerate beta oscillations is unlikely to
result from the possible confounding effects of anesthesia.
Ourdataarealsoimportantinimplyingthattheemergenceof
pathological beta oscillations is appreciably delayed after lesion
induction by 6-OHDA injection. To test this idea directly, we
recorded frontal ECoGs on postoperative days 1, 4, and 15 from
behaving rats (n  5) that had received a 6-OHDA injection on
day0.Theappearanceofexaggeratedbetaoscillationswasindeed
delayed, insofar that a distinct spectral peak at beta frequencies
was not evident in ECoGs recorded on postoperative days 1 and
4,butwasclearlypresentonday15(Fig.6D).Thepeakfrequency
oftheexaggeratedbetaoscillationsinthesebehavinglesionedrats
was 25 Hz (Fig. 6D). As before, we then focused on ECoG
activity around this peak and compared power in the peak beta
band (22–28 Hz) across lesioned and control animals. Peak beta
power in lesioned animals was significantly increased on day 15
compared with days 1 and 4 (Friedman’s ANOVA and Student–
Newman–Keuls tests) (Fig. 6D), as well compared with control
Figure 4. Chronic 6-OHDA lesions, but not acute antagonist treatment, exaggerate beta
oscillations in the subthalamic nucleus. A, Average power spectra of STN-LFPs recorded in
untreatedcontrolanimals(n8),controlsafteracuteantagonisttreatment(n8,“treated
controls”),andchronicallylesionedanimals(n9)duringtheactivatedbrainstate.Thegray
boxesindicatethepeakbetaband(17–23Hz)usedinquantitativeanalysesinCandD.Spectral
powerat50Hz(linenoise)wasremovedforclarity.a.u.,Arbitraryunits.B,Averagepower
spectra of STN-LFPs recorded in the same animals during slow-wave activity. There are no
distinctpeaksinpoweratbetafrequencies.C,D,Averagelogpowerofpeakbetaoscillations
(17–23Hz)inSTN-LFPsacrossexperimentalgroupsandbrainstates.PowervaluesinAandB
werenormalizedbylogarithmictransformationbeforestatisticaltesting.Dataaremeans1
SEM. *p 	 0.01. Note the small error bars (SEM) indicating limited variability between beta
oscillationsindifferentanimals.
Figure 5. Chronic 6-OHDA lesions, but not acute antagonist treatment, exaggerate beta
oscillations in the cerebral cortex. A, Average power spectra of ECoGs recorded in untreated
controlanimals(n8),controlsafteracuteantagonisttreatment(n8,“treatedcontrols”),
and chronically lesioned animals (n  9) during the activated brain state. The gray boxes
indicatethepeakbetaband(17–23Hz)usedinquantitativeanalysesinCandD.Spectralpower
at50Hz(linenoise)wasremovedforclarity.a.u.,Arbitraryunits.B,Averagepowerspectraof
ECoGs recorded in same animals during slow-wave activity. C, D, Average log power of peak
betaoscillations(17–23Hz)inECoGsacrossexperimentalgroupsandbrainstates.Thepower
valuesinAandBwerenormalizedbylogarithmictransformationbeforestatisticaltesting.Data
aremeans1SEM.*p	0.01.Notethesmallerrorbars(SEM)indicatinglimitedvariability
betweenbetaoscillationsindifferentanimals.
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D, E). Note that peak beta power (22–28 Hz) in control animals
was unchanged by saline or antagonist administration (Fig.
6B,C). However, peak beta power in lesioned animals on day 1
was significantly reduced compared with control animals (Man-
n–Whitney test) (Fig. 6, compare D, E). Together, these data
show that beta oscillations in behaving animals only became ex-
aggerated several days after chronic disruption of dopamine
transmission was initiated by 6-OHDA injections.
Discussion
We addressed the critical issue of how inappropriately synchro-
nizedbeta-frequency(15–30Hz)oscillationsariseincorticobasal
gangliacircuitsinPD.Althoughexaggeratedbetaoscillationsare
attenuated by acute dopaminergic therapies, we found that
chronic disruption of dopamine transmission was a prerequisite
for their emergence. Thus, pathological amplification of beta os-
cillationsinthesecircuitsinPDislikelyaconsequenceofplastic-
ity induced by long-term progressive dopamine depletion rather
than an acute network response to loss of dopamine
transmission.
Clinical evidence suggests a functional association between
exaggerated beta oscillations and disease symptoms. Moreover,
theseabnormaloscillationsareacutelysuppressedbydopamine-
replacementtherapies(Brown,2006).Assuch,onemightpredict
that they arise in PD through an acute pharmacological imbal-
ance, that is, they rapidly appear because they are no longer “fil-
tered out” by reduced dopamine. Here, we tested this important
prediction, with notable results. We used a combination of po-
tent and selective antagonists of D1-like and D2-like receptors to
acutely disrupt dopamine transmission in intact animals. These
are the principal receptor classes in the cortex and basal ganglia
(Seamans and Yang, 2004; Surmeier et al., 2007) and, thus, it is
expected that neuronal activity and behavior would be signifi-
cantly altered after their blockade. Indeed, profound catalepsy
developed shortly after antagonist administration (Degos et al.,
2005). Importantly, however, acute disruption of dopamine
transmission did not exaggerate cortical and STN beta oscilla-
tions, although still affecting activity at other frequencies. This
findinghastwomajorimplications.First,althoughexcessivebeta
synchronization might cause paucity or slowing of movement in
PD (see below), these phenomena are not inextricably linked,
insofar that an arguably similar motor deficit may occur in cata-
Figure6. Corticalbetaoscillationsarenotaugmentedbyacuteantagonisttreatmentsinbehavingcontrolanimals,andpathologicalbetaoscillationsaredelayedafter6-OHDAinjectionsin
lesionedanimals.A,RightfrontalECoGsrecordedinarepresentativedopamine-intactratbefore(control)andaftersystemicadministrationofvehicle(saline)oracombinationofselectiveD1and
D2receptorantagonists(SCH-23390at0.5mg/kgandracloprideat2mg/kg).Recordingtimesafterinjectionsareindicated.Calibration:0.5mV,250ms.B,PowerspectraofECoGsrecordedfrom
thesingleanimalinA,andaveragepowerspectraforthegroupofdopamine-intactrats(n5).Recordingtimesafterinjectionsareindicatedinparentheses(inminutes).Thegrayboxesanddashed
linesindicatethepeakbetaband(22–28Hz)andwiderbetaband(19–31Hz),respectively,asusedinquantitativeanalysesinCandD.Notethatantagonisttreatmentdidnotaugmentbeta
oscillations.C,Totalpowerofpeakbetaoscillations(22–28Hz,gray)andwiderbetaoscillations(19–31Hz,black)averagedacrossalldopamine-intactratsandtreatments.Dataaremeans1
SEM.Animalswerefullycataleptic10–15minafteradministrationofD1/D2antagonists.D,Left,AveragepowerspectraofECoGsrecordedipsilateralto6-OHDAlesionsinbehavingrats(n5)on
postoperativedays1,4,and15.Right,Comparisonofpeakbetapower(22–28Hz)inECoGsrecordedfromlesioned,behavingrats.Dataaremedians(blacklines)and25th/75thpercentiles(boxes).
*p	0.05.E,Peakbetapower(22–28Hz)inECoGsrecordedfromcontrolbehavingrats.
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tagonist treatment was ineffective at inducing excessive beta os-
cillations, they must instead arise through relatively slow and
long-termadaptiveand/orcompensatoryprocesses.Ourrecord-
ings of cortical activity at several time points after 6-OHDA in-
jections showed that beta oscillations are not exaggerated until
4 d after lesion. This agrees with data from our antagonist
experiments, but is remarkable because striatal extracellular do-
paminelevelsdecreaseto	20%within1hofmidbrain6-OHDA
injections (Svenningsson et al., 1999). Yet, the relatively slow
evolutionofexcessivebetasynchronizationisconsistentwiththe
gradualdevelopmentofotherpathophysiologicalhallmarks,e.g.,
significant losses of dopaminergic fibers from striatum or alter-
ationsinSTNmetabolicactivityareonlydetectable3daftertoxin
injection (Vila et al., 2000). In short, the delayed emergence of
pathological beta oscillations after 6-OHDA injections, or their
absence after acute receptor blockade, does not parallel the rapid
disruption of dopamine transmission that occurs in both cases,
but rather correlates with the genetic, neurochemical, and struc-
tural changes that slowly ensue as compensatory or adaptive se-
quelae in PD and its chronic animal models (Zigmond et al.,
1990; Surmeier et al., 2007). The delayed onset of abnormal beta
oscillations in the 6-OHDA-lesioned rat model of PD may have
behavioral parallels in other PD models, such as 1-methyl-4-
phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated monkeys.
Early motor deficits after acute MPTP toxicity are often dystonic
innature,whereasclassicParkinsonismmaybedelayedbyoneor
more weeks after intoxication (Tabbal et al., 2006). This natural
history is consistent with clinical experience: acute exposure to
dopamine receptor antagonists may cause dystonia and related
dyskinesias,butParkinsonismrequiresmorechronicneuroleptic
use (Ayd, 1961).
Guidedbyclinicalfindings,wedemonstrateherethatchronic
disruption of dopamine transmission after 6-OHDA lesions of
midbraindopamineneuronsleadstoasignificantincreaseinthe
power of beta oscillations in the sensory–motor cortex and STN
ofanesthetizedrats.Theovertsynchronizationofoscillationswas
effectivelylimitedtobetafrequencies,althoughmostotherstud-
ies in animal models of PD have emphasized the emergence of
abnormal oscillations with frequencies of 15 Hz (Bergman et
al.,1998;Boraudetal.,2005;Gatevetal.,2006).Exaggeratedbeta
oscillations were highly dynamic, and their emergence during
anesthesia was brain-state dependent; they arose during global
brain activity analogous to that accompanying the waking state.
Our recordings in alert lesioned animals support this. Thus, the
predominant pattern of oscillatory activity in this rodent model
of PD accurately reflects that seen in unmedicated PD patients.
Although the neural basis of cortical beta oscillations, as mea-
suredinLFPs,isreasonablywellestablished(Rubinoetal.,2006),
this is not the case for STN-LFP oscillations, and particularly
those in this rodent model. We found that abnormal beta oscil-
lationswereexpressedintheSTNof6-OHDA-lesionedratsatthe
levels of single-units, multiunit ensembles, and LFPs. Individual
STN neurons could fire a single spike or a burst of spikes in a
phase-lockedmannerduringeveryoscillatoryLFPcycle,orjusta
proportion of cycles. These rodent data extend and agree with
previous findings in PD patients (Kuhn et al., 2005; Weinberger
etal.,2006).Thus,afterchronic6-OHDAlesions,populationsof
STN neurons tend to engage in synchronized oscillatory firing at
beta frequencies. The underlying postsynaptic currents most
likely summate and generate beta oscillations in STN-LFPs. Our
simultaneous recordings of activity in and around STN directly
demonstrate that pathological beta oscillations are focally ex-
pressed within STN (compared with adjacent structures), thus
supporting inferences from previous clinical studies (Chen et al.,
2006; Weinberger et al., 2006). Subthalamic nucleus neurons are
intrinsic pacemakers, but the stereotypical unit activity we re-
corded in lesioned rats has not been described ex vivo (Bevan et
al., 2002). Although adaptive processes within STN cannot be
disregarded, it thus seems likely that intact STN afferents are
critical for orchestrating excessive beta oscillations generated
therein. Our ECoG data highlight a role for direct cortical inputs
(Magill et al., 2004), but trans-striatal influences via the external
globus pallidus cannot be discounted (Bevan et al., 2002), and
future studies should investigate these candidate mechanisms.
Beta oscillations may subserve intracortical and intercortical
information processing during normal movement preparation
and execution (Rubino et al., 2006). Given that the cortex is the
primaryextrinsicafferentofthebasalganglia,thesamemayhold
true for information processing within and between corticobasal
ganglia circuits. In primates, beta power in the cortex and STN
decreases during movement preparation (or might increase, de-
pendingontheposturalconfiguration),attenuatesfurtheratself-
paced or externally paced movement initiation, and increases
withmovementtermination(Amirnovinetal.,2004;Kuhnetal.,
2004; Doyle et al., 2005; Williams et al., 2005; Devos et al., 2006;
Rubinoetal.,2006).Undernormalconditions,withdopaminer-
gic innervation intact, appropriately synchronized beta oscilla-
tions(atlowlevels)maythusbeadvantageousforsensory–motor
information processing and task performance (MacKay, 1997;
Baker et al., 1999; Uhlhaas and Singer, 2006). However, in the
caseofPDandassociatedmotorsymptoms,particularlyakinesia/
bradykinesia,excessivebetasynchronizationmaybecounterpro-
ductive or truly pathological (Brown, 2006; Uhlhaas and Singer,
2006).Buthowmightpathologicalbetasynchronizationactually
impair motor processing? Assuming that the cortex (and basal
ganglia)usesaneuralcodeinwhichtheprecisetimingofoutputs
is,orcanbe,fullyusedbytargetedneurons(Boraudetal.,2005),
then during synchronized activity, the potential information en-
coded by a neuronal population will be smaller than the sum of
informationencodedbyitssingleelementsbecauseofthemutual
information shared between neurons (Averbeck et al., 2006). In
extreme cases, such as that of the STN in PD, synchronization
across a neuronal population can reduce distinct information
carrying channels to unity. We found that the mutual informa-
tion between STN neuronal ensembles was significantly in-
creased in lesioned animals compared with controls. This re-
duced capacity for information encoding in the STN could
underlie dysfunction. Attenuation of information through
pathological synchrony will also affect STN targets, because syn-
chronized activity is preferentially propagated at postsynaptic
sites through temporal summation. In line with this, beta oscil-
lations in the STN are coherent with those in the output nuclei
and cortex in both the 6-OHDA-lesioned rat model (Sharott et
al., 2005) and PD patients (Brown, 2006). The net result is that
the pathological beta synchronization evident in our rodent
model of PD, and PD patients, will impair information coding
capacity in cortical-basal ganglia circuits during motor process-
ing. However, the firing rates of STN neurons also significantly
increased after 6-OHDA lesions, suggesting that rate changes
may also be of great importance in Parkinsonism.
To conclude, the 6-OHDA-lesioned rat model of PD is now
well placed to give further insights into the mechanisms under-
lying the exaggerated beta oscillations seen in idiopathic PD, and
will further aid the identification of novel therapeutic targets.
When pathological beta oscillations become established through
4804 • J.Neurosci.,April30,2008 • 28(18):4795–4806 Malletetal.•PathologicalBetaOscillationsinParkinsonismchronic dopamine loss, acute drug therapies can attenuate them,
with concomitant relief from movement symptoms (Brown,
2006). The abnormal beta activity exhibited by this model thus
offersaclinicallyrelevantbiomarkerthatcanbeexploitedindrug
discovery.Moreover,becausetheemergenceofpathologicalbeta
oscillations is appreciably delayed after the initial insult to dopa-
mine neurons, there is a window of opportunity to prevent the
underling plasticity through alternative disease-modifying strat-
egies and counteract the evolving beta oscillations for symptom-
atic benefit.
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